Krystal Biotech, Inc.
$363.84
+4.48 (+1.25%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +16.4%
- 3 Months
- +24.1%
- YTD
- +47.6%
- 1 Year
- +146.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 39.1%
- Largest decline max drawdown, since Aug 2025
- -17.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 2.51
Own KRYS?
See how KRYS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.